Expression of proteins associated with adipocyte lipolysis was significantly changed in the adipose tissues of the obese spontaneously hypertensive/NDmcr-cp rat

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Chang, Jie ^a,b   Oikawa, Shinji ^a   Iwahashi, Hitoshi ^c,e   Kitagawa, Emiko ^c,f   Takeuchi, Ichiro ^d   Yuda, Masao ^a   Aoki, Chieko ^a   Yamada, Yoshiji ^a   Ichihara, Gaku ^b   Kato, Masashi ^b   Ichihara, Sahoko ^a  

^a MIE UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^d NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^e GIFU UNIVERSITY   (Japan)

^f Applied Science   (Japan)

Author keywords

Adipose tissue; DNA microarray; Lipolysis; Metabolic syndrome; Proteomics

Indexed keywords

CARBOXYLESTERASE; CARBOXYLESTERASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; DOWN REGULATION; EPIDIDYMIS FAT; GENE EXPRESSION; GENE IDENTIFICATION; HYPERTENSION; KOLETSKY RAT; LIPOLYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RNA EXTRACTION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

EID: 84896895747     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-8     Document Type: Article

References (40)

1. Obesity as a medical problem. Kopelman PG, Nature 2000 404 635 643 10766250
2. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Wilson PWF, D'Agostino RB, Parise H, et al. Circulation 2005 112 3066 3072 10.1161/CIRCULATIONAHA.105.539528 16275870
3. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals. McLaughlin T, Abbasi F, Lamendola C, et al. Arch Intern Med 2007 167 642 648 10.1001/archinte.167.7. 642 17420421
4. How are we diagnosing cardiometabolic risk in primary care settings? Gohdes D, Amundson H, Oser CS, et al. Prim Care Diabetes 2009 3 29 35 10.1016/j.pcd.2008.12.002 19155195
5. Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat. Morricone L, Malavazos AE, Coman C, et al. Obes Res 2002 10 489 498 10.1038/oby.2002.67 12055325
6. Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women. Marfella R, Esposito K, Siniscalchi M, et al. Diabetes Care 2004 27 47 52 10.2337/diacare.27.1.47 14693965
7. Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension. Striffler JS, Bhathena SJ, Michaelis OE 4th, et al. Metabolism 1998 47 1199 1204 10.1016/S0026-0495(98)90323-7 9781621
8. Obese spontaneously hypertensive rats-a model for study of atherosclerosis. Koletsky S, Exp Mol Pathol 1973 19 53 60 10.1016/0014-4800(73) 90040-3 4721724
9. Obese and Hypertensive SHR/NDmcr-cp rats-A model of metabolic syndrome. Yamamoto J, Ikeda K, Yamori Y, Adiposcience 2005 2 243 248
10. Systems-wide chicken DNA microarrays, gene expression profiling, and discovery of functional genes. Cogburn LA, Wang X, Carre W, et al. Poult Sci 2003 82 939 951 10.1093/ps/82.6.939 12817449
11. The application of DNA microarrays in gene expression analysis. van Hal NL, Vorst O, van Houwelingen AM, et al. J Biotechnol 2000 78 271 280 10.1016/S0168-1656(00)00204-2 10751688
12. Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. Wang D, Park JS, Chu JS, et al. J Biol Chem 2004 279 43725 44334 10.1074/jbc.M407368200 15302865
13. Application of proteomics to the study of cardiovascular biology. Macri J, Rapundalo ST, Trends Cardiovasc Med 2001 11 66 75 10.1016/S1050-1738(01) 00088-3 11530295
14. Adipose tissue as an endocrine organ. Ahima RS, Flier JS, Trends Endocrinol Metab 2000 11 327 332 10.1016/S1043-2760(00)00301-5 10996528
15. Altered gene and protein expression in liver of the obese spontaneously hypertensive/NDmcr-cp rat. Chang J, Oikawa S, Ichihara G, et al. Nutr Metab 2012 9 87 10.1186/1743-7075-9-87
16. Serial changes in adipocytokines and cardiac function in a rat model of the metabolic syndrome. Yamaguchi T, Kitamori K, Ichihara G, et al. Clin Exp Pharmacol Physiol 2013 40 443 448 10.1111/1440-1681.12107 23659633
17. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure. Ichihara S, Noda A, Nagata K, et al. Cardiovasc Res 2006 69 726 735 10.1016/j.cardiores. 2005.08.001 16165109
18. Evaluation of toxicity of the mycotoxin citrinin using yeast ORF DNA microarray and Oligo DNA microarray. Iwahashi H, Kitagawa E, Suzuki Y, et al. BMC Genomics 2007 8 95 10.1186/1471-2164-8-95 17408496
19. Proteomic identification of carbonylated proteins in the monkey hippocampus after ischemia-reperfusion. Oikawa S, Yamada T, Minohata T, et al. Free Radic Biol Med 2009 46 1472 1477 10.1016/j.freeradbiomed.2009.02.029 19272443
20. Transcriptomic and proteomic profiling of two porcine tissues using high-throughput technologies. Hornshøj H, Bendixen E, Conley LN, et al. BMC Genomics 2009 10 30 10.1186/1471-2164-10-30 19152685
21. Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models. Rogers S, Girolami M, Kolch W, et al. Bioinformatics 2008 24 2894 2900 10.1093/bioinformatics/btn553 18974169
22. Partial genome scale analysis of gene expression in human adipose tissue using DNA array. Gabrielsson BL, Carlsson B, Carlsson LM, Obes Res 2000 8 374 384 10.1038/oby.2000.45 10968729
23. DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. López IP, Marti A, Milagro FI, et al. Obes Res 2003 11 188 194 10.1038/oby.2003.30 12582213
24. Carboxylesterase 3 (EC 3.1.1.1) is a major adipocyte lipase. Soni KG, Lehner R, Metalnikov P, et al. J Biol Chem 2004 279 40683 40689 10.1074/jbc.M400541200 15220344
25. The carboxylesterase gene family from Arabidopsis thaliana. Marshall SD, Putterill JJ, Plummer KM, et al. J Mol Evol 2003 57 487 500 10.1007/s00239-003- 2492-8 14738307
26. On the homology of the active-site peptides of liver carboxylesterases. Augusteyn RC, de Jersey J, Webb EC, et al. Biochim Biophys Acta 1969 171 128 137 10.1016/0005-2744(69)90112-0 4884138
27. Lipopolysaccharide downregulates carbolesterases 1 and 2 and reduces hydrolysis activity in vitro and in vivo via p38MAPK-NF-kappaB pathway. Mao Z, Li Y, Peng Y, et al. Toxicol Lett 2011 201 213 220 10.1016/j.toxlet.2011.01.002 21237253
28. Human carboxylesterases and their role in xenobiotic and endobiotic metabolism. Ross MK, Crow JA, J Biochem Mol Toxicol 2007 21 187 196 10.1002/jbt.20178 17936933
29. Triacylglycerol hydrolase: role in intracellular lipid metabolism. Dolinsky VW, Gilham D, Alam M, et al. Cell Mol Life Sci 2004 61 1633 1651 15224187
30. Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. Wei E, Ben Ali Y, Lyon J, et al. Cell Metab 2010 11 183 193 10.1016/j.cmet.2010.02.005 20197051
31. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Zimmermann R, Strauss JG, Haemmerle G, et al. Science 2004 306 1383 1386 10.1126/science.1100747 15550674
32. Liver triacylglycerol lipases. Quiroga AD, Lehner R, Biochim Biophys Acta 2012 1821 762 769 10.1016/j.bbalip.2011.09.007 21963564
33. Identification, cloning, expression, and purificationof three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglyceroltransacylase activities. Jenkins CM, Mancuso DJ, Yan W, et al. J Biol Chem 2004 279 48968 48975 10.1074/jbc.M407841200 15364929
34. Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. Taschler U, Radner FP, Heier C, et al. J Biol Chem 2011 286 17467 17477 10.1074/jbc.M110.215434 21454566
35. Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Desvergne B, Michalik L, Wahli W, Mol Endocrinol 2004 18 1321 1332 10.1210/me.2004-0088 15087471
36. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Feige JN, Gelman L, Michalik L, et al. Prog Lipid Res 2006 45 120 159 10.1016/j.plipres.2005.12.002 16476485
37. Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives. Grimaldi PA, Cell Mol Life Sci 2007 64 2459 2464 10.1007/s00018-007-7278-5 17876521
38. PPARs, obesity, and inflammation. Stienstra R, Duval C, Müller M, et al. PPAR Res 2007 2007 95974 17389767
39. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Ong KT, Mashek MT, Bu SY, et al. Hepatology 2011 53 116 126 10.1002/hep.24006 20967758
40. Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling. Rakhshandehroo M, Sanderson LM, Matilainen M, et al. PPAR Res 2007 2007 26839 18288265